Explain "black box" AI without disclosing proprietary research.
Show superior molecule design than competition.
Visualize invisible logic to gain investor trust.
Closed £35M Series B funding round.
Featured in NVIDIA's GTC Paris Keynote 2025.
Secured CNN program coverage.

In this project, we had to show the hidden logic of LabGenius’ machine learning platform and EVA molecule evolution. Emphasis was needed on the critical difference between a standard antibody and a LabGenius-optimised one, highlighting how it solves the problem of off-tumour toxicity, killing cancer cells while leaving healthy tissue alone.

Trusted by some of the world's leading pharmaceutical, biotech and medical communications teams - including AstraZeneca, Pfizer, Sanofi, Takeda, Lundbeck and Samsung Biologics.



















